๐ŸŒ ๐—ฆ๐—ฒ๐—ฝ๐˜๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ ๐—ถ๐˜€ ๐—ก๐—ฒ๐˜„๐—ฏ๐—ผ๐—ฟ๐—ป ๐—ฆ๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—”๐˜„๐—ฎ๐—ฟ๐—ฒ๐—ป๐—ฒ๐˜€๐˜€ ๐— ๐—ผ๐—ป๐˜๐—ต! ๐ŸŒŸ

Globally, around 140 million babies are born each year, and many countries have implemented newborn screening programs to identify serious disorders early. These screenings can prevent severe disabilities or fatalities by ensuring timely treatment.

In various regions, newborn screening has the potential to identify thousands of infants with conditions that require immediate intervention. For instance, in the European Union, approximately 1 in 1,000 babies is affected by a condition included in standard screening panels.

Organizations worldwide are working tirelessly to expand screening programs to more countries, aiming for equitable access for all newborns.

Join us in raising awareness about the importance of newborn screening and advocating for improvements in healthcare access for every child! ๐Ÿ’š

#NewbornScreening #GlobalHealth #SaveLives #EarlyDetection #PublicHealth #ChildHealth #Advocacy #RareDiseases #FamilySupport #NBSAwareness #SCABPharmacy